Wrapping up the bad news - HIV assembly and release

Retrovirology

Volumn 10, Issue 1, 2013, Pages

  Meng, Bo ^a   Lever, Andrew M L ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

ALIX; Assembly; Budding; ESCRT; HIV; NEDD

Indexed keywords

ALIX PROTEIN; ESCRT PROTEIN; ESCRT1 PROTEIN; ESCRT2 PROTEIN; ESCRT3 PROTEIN; GAG PROTEIN; GENOMIC RNA; UBIQUITIN PROTEIN LIGASE NEDD4; UNCLASSIFIED DRUG; VIRUS PROTEIN;

CELL COMPOSITION; HUMAN IMMUNODEFICIENCY VIRUS; NONHUMAN; PROTEIN ASSEMBLY; PROTEIN DOMAIN; PROTEIN INTERACTION; PROTEIN PROCESSING; REVIEW; VIROGENESIS; VIRUS ASSEMBLY; VIRUS CELL TRANSFORMATION; VIRUS RELEASE;

CALCIUM-BINDING PROTEINS; CELL CYCLE PROTEINS; ENDOSOMAL SORTING COMPLEXES REQUIRED FOR TRANSPORT; GAG GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; HIV INFECTIONS; HIV-1; HOST-PATHOGEN INTERACTIONS; HUMANS; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEOLYSIS; UBIQUITIN-PROTEIN LIGASES; VIRUS ASSEMBLY; VIRUS RELEASE;

EID: 84872112730     PISSN: None     EISSN: 17424690     Source Type: Journal    
DOI: 10.1186/1742-4690-10-5     Document Type: Review

References (182)

1. Gottlinger HG, Dorfman T, Sodroski JG, Haseltine WA. Effect of mutations affecting the p6 gag protein on human immunodeficiency virus particle release. Proc Natl Acad Sci U S A 1991, 88:3195-3199. 10.1073/pnas.88.8.3195, 51412, 2014240.
2. Huang M, Orenstein JM, Martin MA, Freed EO. p6Gag is required for particle production from full-length human immunodeficiency virus type 1 molecular clones expressing protease. J Virol 1995, 69:6810-6818. 189593, 7474093.
3. Wollert T, Yang D, Ren X, Lee HH, Im YJ, Hurley JH. The ESCRT machinery at a glance. J Cell Sci 2009, 122:2163-2166. 10.1242/jcs.029884, 2723142, 19535731.
4. Caballe A, Martin-Serrano J. ESCRT machinery and cytokinesis: the road to daughter cell separation. Traffic 2011, 12:1318-1326. 10.1111/j.1600-0854.2011.01244.x, 21722282.
5. Campbell S, Vogt VM. Self-assembly in vitro of purified CA-NC proteins from Rous sarcoma virus and human immunodeficiency virus type 1. J Virol 1995, 69:6487-6497. 189550, 7666550.
6. Campbell S, Rein A. In vitro assembly properties of human immunodeficiency virus type 1 Gag protein lacking the p6 domain. J Virol 1999, 73:2270-2279. 104472, 9971810.
7. Ganser BK, Li S, Klishko VY, Finch JT, Sundquist WI. Assembly and analysis of conical models for the HIV-1 core. Science 1999, 283:80-83. 10.1126/science.283.5398.80, 9872746.
8. Datta SA, Heinrich F, Raghunandan S, Krueger S, Curtis JE, Rein A, Nanda H. HIV-1 Gag extension: conformational changes require simultaneous interaction with membrane and nucleic acid. J Mol Biol 2011, 406:205-214. 10.1016/j.jmb.2010.11.051, 3046808, 21134384.
9. Hogue IB, Hoppe A, Ono A. Quantitative fluorescence resonance energy transfer microscopy analysis of the human immunodeficiency virus type 1 Gag-Gag interaction: relative contributions of the CA and NC domains and membrane binding. J Virol 2009, 83:7322-7336. 10.1128/JVI.02545-08, 2704781, 19403686.
10. Nikolaitchik OA, Gorelick RJ, Leavitt MG, Pathak VK, Hu WS. Functional complementation of nucleocapsid and late domain PTAP mutants of human immunodeficiency virus type 1 during replication. Virology 2008, 375:539-549. 10.1016/j.virol.2008.02.026, 2459335, 18353416.
11. Sette P, Dussupt V, Bouamr F. Identification of the HIV-1 NC Binding Interface in Alix Bro1 Reveals a Role for RNA. J Virol 2012, 86:11608-11615. 10.1128/JVI.01260-12, 22896625.
12. Langelier C, von Schwedler UK, Fisher RD, De Domenico I, White PL, Hill CP, Kaplan J, Ward D, Sundquist WI. Human ESCRT-II complex and its role in human immunodeficiency virus type 1 release. J Virol 2006, 80:9465-9480. 10.1128/JVI.01049-06, 1617254, 16973552.
13. Carlson LA, Hurley JH. In vitro reconstitution of the ordered assembly of the endosomal sorting complex required for transport at membrane-bound HIV-1 Gag clusters. Proc Natl Acad Sci U S A 2012, 109:16928-16933. 10.1073/pnas.1211759109, 23027949.
14. Dorman N, Lever A. Comparison of viral genomic RNA sorting mechanisms in human immunodeficiency virus type 1 (HIV-1), HIV-2, and Moloney murine leukemia virus. J Virol 2000, 74:11413-11417. 10.1128/JVI.74.23.11413-11417.2000, 113248, 11070043.
15. Butsch M, Boris-Lawrie K. Translation is not required To generate virion precursor RNA in human immunodeficiency virus type 1-infected T cells. J Virol 2000, 74:11531-11537. 10.1128/JVI.74.24.11531-11537.2000, 112433, 11090150.
16. Poon DT, Chertova EN, Ott DE. Human immunodeficiency virus type 1 preferentially encapsidates genomic RNAs that encode Pr55(Gag): functional linkage between translation and RNA packaging. Virology 2002, 293:368-378. 10.1006/viro.2001.1283, 11886257.
17. Liang C, Hu J, Russell RS, Wainberg MA. Translation of Pr55(gag) augments packaging of human immunodeficiency virus type 1 RNA in a cis-acting manner. AIDS Res Hum Retroviruses 2002, 18:1117-1126. 10.1089/088922202320567851, 12396450.
18. Kaye JF, Lever AM. Human immunodeficiency virus types 1 and 2 differ in the predominant mechanism used for selection of genomic RNA for encapsidation. J Virol 1999, 73:3023-3031. 104062, 10074152.
19. Lever AM. HIV-1 RNA packaging. Adv Pharmacol 2007, 55:1-32.
20. Lu K, Heng X, Summers MF. Structural determinants and mechanism of HIV-1 genome packaging. J Mol Biol 2011, 410:609-633. 10.1016/j.jmb.2011.04.029, 3139105, 21762803.
21. Bell NM, Kenyon JC, Balasubramanian S, Lever AM. Comparative structural effects of HIV-1 Gag and nucleocapsid proteins in binding to and unwinding of the viral RNA packaging signal. Biochemistry 2012, 51:3162-3169. 10.1021/bi2017969, 22448757.
22. Feng YX, Copeland TD, Henderson LE, Gorelick RJ, Bosche WJ, Levin JG, Rein A. HIV-1 nucleocapsid protein induces "maturation" of dimeric retroviral RNA in vitro. Proc Natl Acad Sci U S A 1996, 93:7577-7581. 10.1073/pnas.93.15.7577, 38788, 8755517.
23. Fu W, Gorelick RJ, Rein A. Characterization of human immunodeficiency virus type 1 dimeric RNA from wild-type and protease-defective virions. J Virol 1994, 68:5013-5018. 236443, 8035501.
24. Druillennec S, Caneparo A, de Rocquigny H, Roques BP. Evidence of interactions between the nucleocapsid protein NCp7 and the reverse transcriptase of HIV-1. J Biol Chem 1999, 274:11283-11288. 10.1074/jbc.274.16.11283, 10196217.
25. Huang M, Zensen R, Cho M, Martin MA. Construction and characterization of a temperature-sensitive human immunodeficiency virus type 1 reverse transcriptase mutant. J Virol 1998, 72:2047-2054. 109498, 9499059.
26. Lener D, Tanchou V, Roques BP, Le Grice SF, Darlix JL. Involvement of HIV-I nucleocapsid protein in the recruitment of reverse transcriptase into nucleoprotein complexes formed in vitro. J Biol Chem 1998, 273:33781-33786. 10.1074/jbc.273.50.33781, 9837967.
27. Darlix JL, Godet J, Ivanyi-Nagy R, Fosse P, Mauffret O, Mely Y. Flexible nature and specific functions of the HIV-1 nucleocapsid protein. J Mol Biol 2011, 410:565-581. 10.1016/j.jmb.2011.03.037, 21762801.
28. Jouvenet N, Bieniasz PD, Simon SM. Imaging the biogenesis of individual HIV-1 virions in live cells. Nature 2008, 454:236-240. 10.1038/nature06998, 2708942, 18500329.
29. Jouvenet N, Simon SM, Bieniasz PD. Imaging the interaction of HIV-1 genomes and Gag during assembly of individual viral particles. Proc Natl Acad Sci U S A 2009, 106:19114-19119. 10.1073/pnas.0907364106, 2776408, 19861549.
30. Kutluay SB, Bieniasz PD. Analysis of the initiating events in HIV-1 particle assembly and genome packaging. PLoS Pathog 2010, 6:e1001200. 10.1371/journal.ppat.1001200, 2987827, 21124996.
31. Ajamian L, Abrahamyan L, Milev M, Ivanov PV, Kulozik AE, Gehring NH, Mouland AJ. Unexpected roles for UPF1 in HIV-1 RNA metabolism and translation. RNA 2008, 14:914-927. 10.1261/rna.829208, 2327365, 18369187.
32. Zimmerman C, Klein KC, Kiser PK, Singh AR, Firestein BL, Riba SC, Lingappa JR. Identification of a host protein essential for assembly of immature HIV-1 capsids. Nature 2002, 415:88-92. 10.1038/415088a, 11780123.
33. Reed JC, Molter B, Geary CD, McNevin J, McElrath J, Giri S, Klein KC, Lingappa JR. HIV-1 Gag co-opts a cellular complex containing DDX6, a helicase that facilitates capsid assembly. J Cell Biol 2012, 198:439-456. 10.1083/jcb.201111012, 22851315.
34. Tang Y, Winkler U, Freed EO, Torrey TA, Kim W, Li H, Goff SP, Morse HC. 3rd: Cellular motor protein KIF-4 associates with retroviral Gag. J Virol 1999, 73:10508-10513. 113106, 10559369.
35. Dong X, Li H, Derdowski A, Ding L, Burnett A, Chen X, Peters TR, Dermody TS, Woodruff E, Wang JJ, Spearman P. AP-3 directs the intracellular trafficking of HIV-1 Gag and plays a key role in particle assembly. Cell 2005, 120:663-674. 10.1016/j.cell.2004.12.023, 15766529.
36. Batonick M, Favre M, Boge M, Spearman P, Honing S, Thali M. Interaction of HIV-1 Gag with the clathrin-associated adaptor AP-2. Virology 2005, 342:190-200. 10.1016/j.virol.2005.08.001, 16139856.
37. St Johnston D, Beuchle D, Nusslein-Volhard C. Staufen, a gene required to localize maternal RNAs in the Drosophila egg. Cell 1991, 66:51-63. 10.1016/0092-8674(91)90138-O, 1712672.
38. Irion U, St Johnston D. bicoid RNA localization requires specific binding of an endosomal sorting complex. Nature 2007, 445:554-558. 10.1038/nature05503, 1997307, 17268469.
39. Sherer NM, Swanson CM, Papaioannou S, Malim MH. Matrix mediates the functional link between human immunodeficiency virus type 1 RNA nuclear export elements and the assembly competency of Gag in murine cells. J Virol 2009, 83:8525-8535. 10.1128/JVI.00699-09, 2738188, 19535446.
40. Mouland AJ, Mercier J, Luo M, Bernier L, DesGroseillers L, Cohen EA. The double-stranded RNA-binding protein Staufen is incorporated in human immunodeficiency virus type 1: evidence for a role in genomic RNA encapsidation. J Virol 2000, 74:5441-5451. 10.1128/JVI.74.12.5441-5451.2000, 112028, 10823848.
41. Chatel-Chaix L, Clement JF, Martel C, Beriault V, Gatignol A, DesGroseillers L, Mouland AJ. Identification of Staufen in the human immunodeficiency virus type 1 Gag ribonucleoprotein complex and a role in generating infectious viral particles. Mol Cell Biol 2004, 24:2637-2648. 10.1128/MCB.24.7.2637-2648.2004, 371130, 15024055.
42. Zhang Y, Barklis E. Nucleocapsid protein effects on the specificity of retrovirus RNA encapsidation. J Virol 1995, 69:5716-5722. 189431, 7637017.
43. Chukkapalli V, Oh SJ, Ono A. Opposing mechanisms involving RNA and lipids regulate HIV-1 Gag membrane binding through the highly basic region of the matrix domain. Proc Natl Acad Sci U S A 2012, 107:1600-1605.
44. Tang C, Loeliger E, Luncsford P, Kinde I, Beckett D, Summers MF. Entropic switch regulates myristate exposure in the HIV-1 matrix protein. Proc Natl Acad Sci U S A 2004, 101:517-522. 10.1073/pnas.0305665101, 327179, 14699046.
45. Spearman P, Horton R, Ratner L, Kuli-Zade I. Membrane binding of human immunodeficiency virus type 1 matrix protein in vivo supports a conformational myristyl switch mechanism. J Virol 1997, 71:6582-6592. 191936, 9261380.
46. Saad JS, Miller J, Tai J, Kim A, Ghanam RH, Summers MF. Structural basis for targeting HIV-1 Gag proteins to the plasma membrane for virus assembly. Proc Natl Acad Sci U S A 2006, 103:11364-11369. 10.1073/pnas.0602818103, 1544092, 16840558.
47. Briggs JA, Simon MN, Gross I, Krausslich HG, Fuller SD, Vogt VM, Johnson MC. The stoichiometry of Gag protein in HIV-1. Nat Struct Mol Biol 2004, 11:672-675. 10.1038/nsmb785, 15208690.
48. Morita E, Sundquist WI. Retrovirus budding. Annu Rev Cell Dev Biol 2004, 20:395-425. 10.1146/annurev.cellbio.20.010403.102350, 15473846.
49. Nagashima S, Takahashi M, Jirintai S, Tanaka T, Nishizawa T, Yasuda J, Okamoto H. Tumour susceptibility gene 101 and the vacuolar protein sorting pathway are required for the release of hepatitis E virions. J Gen Virol 2011, 92:2838-2848. 10.1099/vir.0.035378-0, 21880841.
50. Garrus JE, von Schwedler UK, Pornillos OW, Morham SG, Zavitz KH, Wang HE, Wettstein DA, Stray KM, Cote M, Rich RL, et al. Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding. Cell 2001, 107:55-65. 10.1016/S0092-8674(01)00506-2, 11595185.
51. VerPlank L, Bouamr F, LaGrassa TJ, Agresta B, Kikonyogo A, Leis J, Carter CA. Tsg101, a homologue of ubiquitin-conjugating (E2) enzymes, binds the L domain in HIV type 1 Pr55(Gag). Proc Natl Acad Sci U S A 2001, 98:7724-7729. 10.1073/pnas.131059198, 35409, 11427703.
52. Martin-Serrano J, Zang T, Bieniasz PD. HIV-1 and Ebola virus encode small peptide motifs that recruit Tsg101 to sites of particle assembly to facilitate egress. Nat Med 2001, 7:1313-1319. 10.1038/nm1201-1313, 11726971.
53. Demirov DG, Ono A, Orenstein JM, Freed EO. Overexpression of the N-terminal domain of TSG101 inhibits HIV-1 budding by blocking late domain function. Proc Natl Acad Sci U S A 2002, 99:955-960. 10.1073/pnas.032511899, 117412, 11805336.
54. Puffer BA, Parent LJ, Wills JW, Montelaro RC. Equine infectious anemia virus utilizes a YXXL motif within the late assembly domain of the Gag p9 protein. J Virol 1997, 71:6541-6546. 191930, 9261374.
55. Strack B, Calistri A, Craig S, Popova E, Gottlinger HG. AIP1/ALIX is a binding partner for HIV-1 p6 and EIAV p9 functioning in virus budding. Cell 2003, 114:689-699. 10.1016/S0092-8674(03)00653-6, 14505569.
56. Dilley KA, Gregory D, Johnson MC, Vogt VM. An LYPSL late domain in the gag protein contributes to the efficient release and replication of Rous sarcoma virus. J Virol 2010, 84:6276-6287. 10.1128/JVI.00238-10, 2903267, 20392845.
57. Zhai Q, Fisher RD, Chung HY, Myszka DG, Sundquist WI, Hill CP. Structural and functional studies of ALIX interactions with YPX(n)L late domains of HIV-1 and EIAV. Nat Struct Mol Biol 2008, 15:43-49. 10.1038/nsmb1319, 18066081.
58. Yuan B, Campbell S, Bacharach E, Rein A, Goff SP. Infectivity of Moloney murine leukemia virus defective in late assembly events is restored by late assembly domains of other retroviruses. J Virol 2000, 74:7250-7260. 10.1128/JVI.74.16.7250-7260.2000, 112246, 10906179.
59. Martin-Serrano J, Eastman SW, Chung W, Bieniasz PD. HECT ubiquitin ligases link viral and cellular PPXY motifs to the vacuolar protein-sorting pathway. J Cell Biol 2005, 168:89-101. 2171676, 15623582.
60. Xiang Y, Cameron CE, Wills JW, Leis J. Fine mapping and characterization of the Rous sarcoma virus Pr76gag late assembly domain. J Virol 1996, 70:5695-5700. 190537, 8764091.
61. Parent LJ, Bennett RP, Craven RC, Nelle TD, Krishna NK, Bowzard JB, Wilson CB, Puffer BA, Montelaro RC, Wills JW. Positionally independent and exchangeable late budding functions of the Rous sarcoma virus and human immunodeficiency virus Gag proteins. J Virol 1995, 69:5455-5460. 189393, 7636991.
62. Wills JW, Cameron CE, Wilson CB, Xiang Y, Bennett RP, Leis J. An assembly domain of the Rous sarcoma virus Gag protein required late in budding. J Virol 1994, 68:6605-6618. 237081, 8083996.
63. Gottwein E, Bodem J, Muller B, Schmechel A, Zentgraf H, Krausslich HG. The Mason-Pfizer monkey virus PPPY and PSAP motifs both contribute to virus release. J Virol 2003, 77:9474-9485. 10.1128/JVI.77.17.9474-9485.2003, 187385, 12915562.
64. Yasuda J, Hunter E, Nakao M, Shida H. Functional involvement of a novel Nedd4-like ubiquitin ligase on retrovirus budding. EMBO Rep 2002, 3:636-640. 10.1093/embo-reports/kvf132, 1084186, 12101095.
65. Bouamr F, Melillo JA, Wang MQ. Nagashima K, de Los Santos M, Rein A, Goff SP: PPPYVEPTAP motif is the late domain of human T-cell leukemia virus type 1 Gag and mediates its functional interaction with cellular proteins Nedd4 and Tsg101 [corrected]. J Virol 2003, 77:11882-11895. 10.1128/JVI.77.22.11882-11895.2003, 253756, 14581525.
66. Heidecker G, Lloyd PA, Fox K, Nagashima K, Derse D. Late assembly motifs of human T-cell leukemia virus type 1 and their relative roles in particle release. J Virol 2004, 78:6636-6648. 10.1128/JVI.78.12.6636-6648.2004, 416494, 15163754.
67. Le Blanc I, Prevost MC, Dokhelar MC, Rosenberg AR. The PPPY motif of human T-cell leukemia virus type 1 Gag protein is required early in the budding process. J Virol 2002, 76:10024-10029. 10.1128/JVI.76.19.10024-10029.2002, 136533, 12208980.
68. Kikonyogo A, Bouamr F, Vana ML, Xiang Y, Aiyar A, Carter C, Leis J. Proteins related to the Nedd4 family of ubiquitin protein ligases interact with the L domain of Rous sarcoma virus and are required for gag budding from cells. Proc Natl Acad Sci U S A 2001, 98:11199-11204. 10.1073/pnas.201268998, 58707, 11562473.
69. Chung HY, Morita E, von Schwedler U, Muller B, Krausslich HG, Sundquist WI. NEDD4L overexpression rescues the release and infectivity of human immunodeficiency virus type 1 constructs lacking PTAP and YPXL late domains. J Virol 2008, 82:4884-4897. 10.1128/JVI.02667-07, 2346761, 18321968.
70. Sette P, Jadwin JA, Dussupt V, Bello NF, Bouamr F. The ESCRT-associated protein Alix recruits the ubiquitin ligase Nedd4-1 to facilitate HIV-1 release through the LYPXnL L domain motif. J Virol 2010, 84:8181-8192. 10.1128/JVI.00634-10, 2916511, 20519395.
71. Katzmann DJ, Babst M, Emr SD. Ubiquitin-dependent sorting into the multivesicular body pathway requires the function of a conserved endosomal protein sorting complex. ESCRT-I. Cell 2001, 106:145-155.
72. Raymond CK, Howald-Stevenson I, Vater CA, Stevens TH. Morphological classification of the yeast vacuolar protein sorting mutants: evidence for a prevacuolar compartment in class E vps mutants. Mol Biol Cell 1992, 3:1389-1402. 275707, 1493335.
73. Babst M. A protein's final ESCRT. Traffic 2005, 6:2-9. 10.1111/j.1600-0854.2004.00246.x, 15569240.
74. Carlton JG, Martin-Serrano J. Parallels between cytokinesis and retroviral budding: a role for the ESCRT machinery. Science 2007, 316:1908-1912. 10.1126/science.1143422, 17556548.
75. Nabhan JF, Hu R, Oh RS, Cohen SN, Lu Q. Formation and release of arrestin domain-containing protein 1-mediated microvesicles (ARMMs) at plasma membrane by recruitment of TSG101 protein. Proc Natl Acad Sci U S A 2012, 109:4146-4151. 3306724, 22315426.
76. Baietti MF, Zhang Z, Mortier E, Melchior A, Degeest G, Geeraerts A, Ivarsson Y, Depoortere F, Coomans C, Vermeiren E, et al. Syndecan-syntenin-ALIX regulates the biogenesis of exosomes. Nat Cell Biol 2012, 14:677-685. 10.1038/ncb2502, 22660413.
77. Dores MR, Chen B, Lin H, Soh UJ, Paing MM, Montagne WA, Meerloo T, Trejo J. ALIX binds a YPX(3)L motif of the GPCR PAR1 and mediates ubiquitin-independent ESCRT-III/MVB sorting. J Cell Biol 2012, 197:407-419. 10.1083/jcb.201110031, 3341166, 22547407.
78. Pornillos O, Higginson DS, Stray KM, Fisher RD, Garrus JE, Payne M, He GP, Wang HE, Morham SG, Sundquist WI. HIV Gag mimics the Tsg101-recruiting activity of the human Hrs protein. J Cell Biol 2003, 162:425-434. 10.1083/jcb.200302138, 2172688, 12900394.
79. Brass AL, Dykxhoorn DM, Benita Y, Yan N, Engelman A, Xavier RJ, Lieberman J, Elledge SJ. Identification of host proteins required for HIV infection through a functional genomic screen. Science 2008, 319:921-926. 10.1126/science.1152725, 18187620.
80. Janvier K, Pelchen-Matthews A, Renaud JB, Caillet M, Marsh M, Berlioz-Torrent C. The ESCRT-0 component HRS is required for HIV-1 Vpu-mediated BST-2/tetherin down-regulation. PLoS Pathog 2011, 7:e1001265. 10.1371/journal.ppat.1001265, 3033365, 21304933.
81. Neil SJ, Zang T, Bieniasz PD. Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. Nature 2008, 451:425-430. 10.1038/nature06553, 18200009.
82. Babst M, Odorizzi G, Estepa EJ, Emr SD. Mammalian tumor susceptibility gene 101 (TSG101) and the yeast homologue, Vps23p, both function in late endosomal trafficking. Traffic 2000, 1:248-258. 10.1034/j.1600-0854.2000.010307.x, 11208108.
83. Bishop N, Woodman P. TSG101/mammalian VPS23 and mammalian VPS28 interact directly and are recruited to VPS4-induced endosomes. J Biol Chem 2001, 276:11735-11742. 10.1074/jbc.M009863200, 11134028.
84. Kostelansky MS, Schluter C, Tam YY, Lee S, Ghirlando R, Beach B, Conibear E, Hurley JH. Molecular architecture and functional model of the complete yeast ESCRT-I heterotetramer. Cell 2007, 129:485-498. 10.1016/j.cell.2007.03.016, 2065850, 17442384.
85. Pineda-Molina E, Belrhali H, Piefer AJ, Akula I, Bates P, Weissenhorn W. The crystal structure of the C-terminal domain of Vps28 reveals a conserved surface required for Vps20 recruitment. Traffic 2006, 7:1007-1016. 10.1111/j.1600-0854.2006.00440.x, 16749904.
86. Bache KG, Slagsvold T, Cabezas A, Rosendal KR, Raiborg C, Stenmark H. The growth-regulatory protein HCRP1/hVps37A is a subunit of mammalian ESCRT-I and mediates receptor down-regulation. Mol Biol Cell 2004, 15:4337-4346. 10.1091/mbc.E04-03-0250, 515363, 15240819.
87. Stuchell MD, Garrus JE, Muller B, Stray KM, Ghaffarian S, McKinnon R, Krausslich HG, Morham SG, Sundquist WI. The human endosomal sorting complex required for transport (ESCRT-I) and its role in HIV-1 budding. J Biol Chem 2004, 279:36059-36071. 10.1074/jbc.M405226200, 15218037.
88. Eastman SW, Martin-Serrano J, Chung W, Zang T, Bieniasz PD. Identification of human VPS37C, a component of endosomal sorting complex required for transport-I important for viral budding. J Biol Chem 2005, 280:628-636.
89. Morita E, Sandrin V, Alam SL, Eckert DM, Gygi SP, Sundquist WI. Identification of human MVB12 proteins as ESCRT-I subunits that function in HIV budding. Cell Host Microbe 2007, 2:41-53. 10.1016/j.chom.2007.06.003, 2034311, 18005716.
90. Oestreich AJ, Davies BA, Payne JA, Katzmann DJ. Mvb12 is a novel member of ESCRT-I involved in cargo selection by the multivesicular body pathway. Mol Biol Cell 2007, 18:646-657. 1783776, 17151358.
91. Boura E, Rozycki B, Herrick DZ, Chung HS, Vecer J, Eaton WA, Cafiso DS, Hummer G, Hurley JH. Solution structure of the ESCRT-I complex by small-angle X-ray scattering, EPR, and FRET spectroscopy. Proc Natl Acad Sci U S A 2011, 108:9437-9442. 10.1073/pnas.1101763108, 3111319, 21596998.
92. de Souza RF, Aravind L. UMA and MABP domains throw light on receptor endocytosis and selection of endosomal cargoes. Bioinformatics 2010, 26:1477-1480. 10.1093/bioinformatics/btq235, 2881412, 20448139.
93. Stefani F, Zhang L, Taylor S, Donovan J, Rollinson S, Doyotte A, Brownhill K, Bennion J, Pickering-Brown S, Woodman P. UBAP1 is a component of an endosome-specific ESCRT-I complex that is essential for MVB sorting. Curr Biol 2011, 21:1245-1250. 10.1016/j.cub.2011.06.028, 21757351.
94. Agromayor M, Soler N, Caballe A, Kueck T, Freund SM, Allen MD, Bycroft M, Perisic O, Ye Y, McDonald B, et al. The UBAP1 subunit of ESCRT-I interacts with ubiquitin via a SOUBA domain. Structure 2012, 20:414-428. 10.1016/j.str.2011.12.013, 3314968, 22405001.
95. Pornillos O, Alam SL, Davis DR, Sundquist WI. Structure of the Tsg101 UEV domain in complex with the PTAP motif of the HIV-1 p6 protein. Nat Struct Biol 2002, 9:812-817.
96. Rauch S, Martin-Serrano J. Multiple interactions between the ESCRT machinery and arrestin-related proteins: implications for PPXY-dependent budding. J Virol 2011, 85:3546-3556. 10.1128/JVI.02045-10, 3067843, 21191027.
97. Martin-Serrano J, Zang T, Bieniasz PD. Role of ESCRT-I in retroviral budding. J Virol 2003, 77:4794-4804. 10.1128/JVI.77.8.4794-4804.2003, 152150, 12663786.
98. Kostelansky MS, Sun J, Lee S, Kim J, Ghirlando R, Hierro A, Emr SD, Hurley JH. Structural and functional organization of the ESCRT-I trafficking complex. Cell 2006, 125:113-126. 10.1016/j.cell.2006.01.049, 1576341, 16615894.
99. Hierro A, Sun J, Rusnak AS, Kim J, Prag G, Emr SD, Hurley JH. Structure of the ESCRT-II endosomal trafficking complex. Nature 2004, 431:221-225. 10.1038/nature02914, 15329733.
100. Babst M, Katzmann DJ, Snyder WB, Wendland B, Emr SD. Endosome-associated complex, ESCRT-II, recruits transport machinery for protein sorting at the multivesicular body. Dev Cell 2002, 3:283-289. 10.1016/S1534-5807(02)00219-8, 12194858.
101. Williams RL, Urbe S. The emerging shape of the ESCRT machinery. Nat Rev Mol Cell Biol 2007, 8:355-368. 10.1038/nrm2162, 17450176.
102. Wollert T, Hurley JH. Molecular mechanism of multivesicular body biogenesis by ESCRT complexes. Nature 2010, 464:864-869. 10.1038/nature08849, 2851844, 20305637.
103. Teo H, Gill DJ, Sun J, Perisic O, Veprintsev DB, Vallis Y, Emr SD, Williams RL. ESCRT-I core and ESCRT-II GLUE domain structures reveal role for GLUE in linking to ESCRT-I and membranes. Cell 2006, 125:99-111. 10.1016/j.cell.2006.01.047, 16615893.
104. Bajorek M, Schubert HL, McCullough J, Langelier C, Eckert DM, Stubblefield WM, Uter NT, Myszka DG, Hill CP, Sundquist WI. Structural basis for ESCRT-III protein autoinhibition. Nat Struct Mol Biol 2009, 16:754-762. 10.1038/nsmb.1621, 2712734, 19525971.
105. Muziol T, Pineda-Molina E, Ravelli RB, Zamborlini A, Usami Y, Gottlinger H, Weissenhorn W. Structural basis for budding by the ESCRT-III factor CHMP3. Dev Cell 2006, 10:821-830. 10.1016/j.devcel.2006.03.013, 16740483.
106. Xiao J, Chen XW, Davies BA, Saltiel AR, Katzmann DJ, Xu Z. Structural basis of Ist1 function and Ist1-Did2 interaction in the multivesicular body pathway and cytokinesis. Mol Biol Cell 2009, 20:3514-3524. 10.1091/mbc.E09-05-0403, 2719569, 19477918.
107. Shim S, Kimpler LA, Hanson PI. Structure/function analysis of four core ESCRT-III proteins reveals common regulatory role for extreme C-terminal domain. Traffic 2007, 8:1068-1079. 10.1111/j.1600-0854.2007.00584.x, 17547705.
108. Kieffer C, Skalicky JJ, Morita E, De Domenico I, Ward DM, Kaplan J, Sundquist WI. Two distinct modes of ESCRT-III recognition are required for VPS4 functions in lysosomal protein targeting and HIV-1 budding. Dev Cell 2008, 15:62-73. 10.1016/j.devcel.2008.05.014, 2586299, 18606141.
109. Obita T, Saksena S, Ghazi-Tabatabai S, Gill DJ, Perisic O, Emr SD, Williams RL. Structural basis for selective recognition of ESCRT-III by the AAA ATPase Vps4. Nature 2007, 449:735-739. 10.1038/nature06171, 17928861.
110. Samson RY, Obita T, Freund SM, Williams RL, Bell SD. A role for the ESCRT system in cell division in archaea. Science 2008, 322:1710-1713. 10.1126/science.1165322, 19008417.
111. Skalicky JJ, Arii J, Wenzel DM, Stubblefield WM, Katsuyama A, Uter NT, Bajorek M, Myszka DG, Sundquist WI. Interactions of the Human LIP5 Regulatory Protein with Endosomal Sorting Complexes Required for Transport. J Biol Chem 2012, 287:43910-43926. 10.1074/jbc.M112.417899, 23105106.
112. Solomons J, Sabin C, Poudevigne E, Usami Y, Hulsik DL, Macheboeuf P, Hartlieb B, Gottlinger H, Weissenhorn W. Structural basis for ESCRT-III CHMP3 recruitment of AMSH. Structure 2011, 19:1149-1159. 10.1016/j.str.2011.05.011, 3154637, 21827950.
113. Stuchell-Brereton MD, Skalicky JJ, Kieffer C, Karren MA, Ghaffarian S, Sundquist WI. ESCRT-III recognition by VPS4 ATPases. Nature 2007, 449:740-744. 10.1038/nature06172, 17928862.
114. Yang Z, Vild C, Ju J, Zhang X, Liu J, Shen J, Zhao B, Lan W, Gong F, Liu M, et al. Structural basis of molecular recognition between ESCRT-III like protein Vps60 and AAA-ATPase regulator Vta1 in the multi-vesicular body pathway. J Biol Chem 2012, 287:43899-43908. 10.1074/jbc.M112.390724, 23105107.
115. Scott A, Chung HY, Gonciarz-Swiatek M, Hill GC, Whitby FG, Gaspar J, Holton JM, Viswanathan R, Ghaffarian S, Hill CP, Sundquist WI. Structural and mechanistic studies of VPS4 proteins. EMBO J 2005, 24:3658-3669. 10.1038/sj.emboj.7600818, 1276703, 16193069.
116. Martin-Serrano J, Yarovoy A, Perez-Caballero D, Bieniasz PD. Divergent retroviral late-budding domains recruit vacuolar protein sorting factors by using alternative adaptor proteins. Proc Natl Acad Sci U S A 2003, 100:12414-12419. 10.1073/pnas.2133846100, 218772, 14519844.
117. von Schwedler UK, Stuchell M, Muller B, Ward DM, Chung HY, Morita E, Wang HE, Davis T, He GP, Cimbora DM, et al. The protein network of HIV budding. Cell 2003, 114:701-713. 10.1016/S0092-8674(03)00714-1, 14505570.
118. Fisher RD, Chung HY, Zhai Q, Robinson H, Sundquist WI, Hill CP. Structural and biochemical studies of ALIX/AIP1 and its role in retrovirus budding. Cell 2007, 128:841-852. 10.1016/j.cell.2007.01.035, 17350572.
119. Usami Y, Popov S, Gottlinger HG. Potent rescue of human immunodeficiency virus type 1 late domain mutants by ALIX/AIP1 depends on its CHMP4 binding site. J Virol 2007, 81:6614-6622. 10.1128/JVI.00314-07, 1900090, 17428861.
120. Saksena S, Wahlman J, Teis D, Johnson AE, Emr SD. Functional reconstitution of ESCRT-III assembly and disassembly. Cell 2009, 136:97-109. 10.1016/j.cell.2008.11.013, 19135892.
121. Teis D, Saksena S, Judson BL, Emr SD. ESCRT-II coordinates the assembly of ESCRT-III filaments for cargo sorting and multivesicular body vesicle formation. EMBO J 2010, 29:871-883. 10.1038/emboj.2009.408, 2837172, 20134403.
122. Morita E, Sandrin V, McCullough J, Katsuyama A, Baci Hamilton I, Sundquist WI. ESCRT-III protein requirements for HIV-1 budding. Cell Host Microbe 2011, 9:235-242. 10.1016/j.chom.2011.02.004, 3070458, 21396898.
123. Pires R, Hartlieb B, Signor L, Schoehn G, Lata S, Roessle M, Moriscot C, Popov S, Hinz A, Jamin M, et al. A crescent-shaped ALIX dimer targets ESCRT-III CHMP4 filaments. Structure 2009, 17:843-856. 10.1016/j.str.2009.04.007, 2699623, 19523902.
124. Effantin G, Dordor A, Sandrin V, Martinelli N, Sundquist WI, Schoehn G, Weissenhorn W. ESCRT-III CHMP2A and CHMP3 form variable helical polymers in vitro and act synergistically during HIV-1 budding. Cell Microbiol 2012,
125. Wollert T, Wunder C, Lippincott-Schwartz J, Hurley JH. Membrane scission by the ESCRT-III complex. Nature 2009, 458:172-177. 10.1038/nature07836, 2743992, 19234443.
126. Hanson PI, Roth R, Lin Y, Heuser JE. Plasma membrane deformation by circular arrays of ESCRT-III protein filaments. J Cell Biol 2008, 180:389-402. 10.1083/jcb.200707031, 2213594, 18209100.
127. Ghazi-Tabatabai S, Saksena S, Short JM, Pobbati AV, Veprintsev DB, Crowther RA, Emr SD, Egelman EH, Williams RL. Structure and disassembly of filaments formed by the ESCRT-III subunit Vps24. Structure 2008, 16:1345-1356. 10.1016/j.str.2008.06.010, 18786397.
128. Lata S, Schoehn G, Jain A, Pires R, Piehler J, Gottlinger HG, Weissenhorn W. Helical structures of ESCRT-III are disassembled by VPS4. Science 2008, 321:1354-1357. 10.1126/science.1161070, 2758909, 18687924.
129. Bodon G, Chassefeyre R, Pernet-Gallay K, Martinelli N, Effantin G, Hulsik DL, Belly A, Goldberg Y, Chatellard-Causse C, Blot B, et al. Charged multivesicular body protein 2B (CHMP2B) of the endosomal sorting complex required for transport-III (ESCRT-III) polymerizes into helical structures deforming the plasma membrane. J Biol Chem 2011, 286:40276-40286. 10.1074/jbc.M111.283671, 3220537, 21926173.
130. Azmi IF, Davies BA, Xiao J, Babst M, Xu Z, Katzmann DJ. ESCRT-III family members stimulate Vps4 ATPase activity directly or via Vta1. Dev Cell 2008, 14:50-61. 10.1016/j.devcel.2007.10.021, 18194652.
131. Dimaano C, Jones CB, Hanono A, Curtiss M, Babst M. Ist1 regulates Vps4 localization and assembly. Mol Biol Cell 2008, 19:465-474. 2230601, 18032582.
132. Rue SM, Mattei S, Saksena S, Emr SD. Novel Ist1-Did2 complex functions at a late step in multivesicular body sorting. Mol Biol Cell 2008, 19:475-484. 2230597, 18032584.
133. Shestakova A, Hanono A, Drosner S, Curtiss M, Davies BA, Katzmann DJ, Babst M. Assembly of the AAA ATPase Vps4 on ESCRT-III. Mol Biol Cell 2010, 21:1059-1071. 10.1091/mbc.E09-07-0572, 2836958, 20110351.
134. Ward DM, Vaughn MB, Shiflett SL, White PL, Pollock AL, Hill J, Schnegelberger R, Sundquist WI, Kaplan J. The role of LIP5 and CHMP5 in multivesicular body formation and HIV-1 budding in mammalian cells. J Biol Chem 2005, 280:10548-10555. 10.1074/jbc.M413734200, 15644320.
135. Hill CP, Babst M. Structure and function of the membrane deformation AAA ATPase Vps4. Biochim Biophys Acta 2012, 1823:172-181. 10.1016/j.bbamcr.2011.08.017, 3245771, 21925211.
136. Scheuring S, Rohricht RA, Schoning-Burkhardt B, Beyer A, Muller S, Abts HF, Kohrer K. Mammalian cells express two VPS4 proteins both of which are involved in intracellular protein trafficking. J Mol Biol 2001, 312:469-480. 10.1006/jmbi.2001.4917, 11563910.
137. Babst M, Wendland B, Estepa EJ, Emr SD. The Vps4p AAA ATPase regulates membrane association of a Vps protein complex required for normal endosome function. EMBO J 1998, 17:2982-2993. 10.1093/emboj/17.11.2982, 1170638, 9606181.
138. Azmi I, Davies B, Dimaano C, Payne J, Eckert D, Babst M, Katzmann DJ. Recycling of ESCRTs by the AAA-ATPase Vps4 is regulated by a conserved VSL region in Vta1. J Cell Biol 2006, 172:705-717. 10.1083/jcb.200508166, 2063703, 16505166.
139. Yang D, Hurley JH. Structural role of the Vps4-Vta1 interface in ESCRT-III recycling. Structure 2010, 18:976-984. 10.1016/j.str.2010.04.014, 3124813, 20696398.
140. Gonciarz MD, Whitby FG, Eckert DM, Kieffer C, Heroux A, Sundquist WI, Hill CP. Biochemical and structural studies of yeast Vps4 oligomerization. J Mol Biol 2008, 384:878-895. 10.1016/j.jmb.2008.09.066, 2632936, 18929572.
141. Yu Z, Gonciarz MD, Sundquist WI, Hill CP, Jensen GJ. Cryo-EM structure of dodecameric Vps4p and its 2:1 complex with Vta1p. J Mol Biol 2008, 377:364-377. 10.1016/j.jmb.2008.01.009, 2279015, 18280501.
142. Elia N, Sougrat R, Spurlin TA, Hurley JH, Lippincott-Schwartz J. Dynamics of endosomal sorting complex required for transport (ESCRT) machinery during cytokinesis and its role in abscission. Proc Natl Acad Sci U S A 2011, 108:4846-4851. 10.1073/pnas.1102714108, 3064317, 21383202.
143. Jouvenet N, Zhadina M, Bieniasz PD, Simon SM. Dynamics of ESCRT protein recruitment during retroviral assembly. Nat Cell Biol 2011, 13:394-401. 10.1038/ncb2207, 3245320, 21394083.
144. Baumgartel V, Ivanchenko S, Dupont A, Sergeev M, Wiseman PW, Krausslich HG, Brauchle C, Muller B, Lamb DC. Live-cell visualization of dynamics of HIV budding site interactions with an ESCRT component. Nat Cell Biol 2011, 13:469-474. 10.1038/ncb2215, 21394086.
145. Fabrikant G, Lata S, Riches JD, Briggs JA, Weissenhorn W, Kozlov MM. Computational model of membrane fission catalyzed by ESCRT-III. PLoS Comput Biol 2009, 5:e1000575. 10.1371/journal.pcbi.1000575, 2773929, 19936052.
146. Usami Y, Popov S, Weiss ER, Vriesema-Magnuson C, Calistri A, Gottlinger HG. Regulation of CHMP4/ESCRT-III function in human immunodeficiency virus type 1 budding by CC2D1A. J Virol 2012, 86:3746-3756. 10.1128/JVI.06539-11, 3302528, 22258254.
147. Martinelli N, Hartlieb B, Usami Y, Sabin C, Dordor A, Miguet N, Avilov SV, Ribeiro EA, Gottlinger H, Weissenhorn W. CC2D1A is a regulator of ESCRT-III CHMP4B. J Mol Biol 2012, 419:75-88. 10.1016/j.jmb.2012.02.044, 22406677.
148. Fyfe I, Schuh AL, Edwardson JM, Audhya A. Association of the endosomal sorting complex ESCRT-II with the Vps20 subunit of ESCRT-III generates a curvature-sensitive complex capable of nucleating ESCRT-III filaments. J Biol Chem 2011, 286:34262-34270. 10.1074/jbc.M111.266411, 3190807, 21835927.
149. Odorizzi G, Katzmann DJ, Babst M, Audhya A, Emr SD. Bro1 is an endosome-associated protein that functions in the MVB pathway in Saccharomyces cerevisiae. J Cell Sci 2003, 116:1893-1903. 10.1242/jcs.00395, 12668726.
150. Martin-Serrano J, Bieniasz PD. A bipartite late-budding domain in human immunodeficiency virus type 1. J Virol 2003, 77:12373-12377. 10.1128/JVI.77.22.12373-12377.2003, 254264, 14581576.
151. Lee S, Joshi A, Nagashima K, Freed EO, Hurley JH. Structural basis for viral late-domain binding to Alix. Nat Struct Mol Biol 2007, 14:194-199. 10.1038/nsmb1203, 2377018, 17277784.
152. Dowlatshahi DP, Sandrin V, Vivona S, Shaler TA, Kaiser SE, Melandri F, Sundquist WI, Kopito RR. ALIX Is a Lys63-Specific Polyubiquitin Binding Protein that Functions in Retrovirus Budding. Dev Cell 2012, 23:1247-1254. 10.1016/j.devcel.2012.10.023, 23201121.
153. Fujii K, Hurley JH, Freed EO. Beyond Tsg101: the role of Alix in 'ESCRTing' HIV-1. Nat Rev Microbiol 2007, 5:912-916. 10.1038/nrmicro1790, 17982468.
154. Odorizzi G. The multiple personalities of Alix. J Cell Sci 2006, 119:3025-3032. 10.1242/jcs.03072, 16868030.
155. Munshi UM, Kim J, Nagashima K, Hurley JH, Freed EO. An Alix fragment potently inhibits HIV-1 budding: characterization of binding to retroviral YPXL late domains. J Biol Chem 2007, 282:3847-3855.
156. Carlton JG, Agromayor M, Martin-Serrano J. Differential requirements for Alix and ESCRT-III in cytokinesis and HIV-1 release. Proc Natl Acad Sci U S A 2008, 105:10541-10546. 10.1073/pnas.0802008105, 2492449, 18641129.
157. Zhai Q, Landesman MB, Chung HY, Dierkers A, Jeffries CM, Trewhella J, Hill CP, Sundquist WI. Activation of the retroviral budding factor ALIX. J Virol 2011, 85:9222-9226. 10.1128/JVI.02653-10, 3165844, 21715492.
158. Kim J, Sitaraman S, Hierro A, Beach BM, Odorizzi G, Hurley JH. Structural basis for endosomal targeting by the Bro1 domain. Dev Cell 2005, 8:937-947. 10.1016/j.devcel.2005.04.001, 2862258, 15935782.
159. McCullough J, Fisher RD, Whitby FG, Sundquist WI, Hill CP. ALIX-CHMP4 interactions in the human ESCRT pathway. Proc Natl Acad Sci U S A 2008, 105:7687-7691. 10.1073/pnas.0801567105, 2409388, 18511562.
160. Dussupt V, Javid MP, Abou-Jaoude G, Jadwin JA, de La Cruz J, Nagashima K, Bouamr F. The nucleocapsid region of HIV-1 Gag cooperates with the PTAP and LYPXnL late domains to recruit the cellular machinery necessary for viral budding. PLoS Pathog 2009, 5:e1000339. 10.1371/journal.ppat.1000339, 2651531, 19282983.
161. Popov S, Popova E, Inoue M, Gottlinger HG. Human immunodeficiency virus type 1 Gag engages the Bro1 domain of ALIX/AIP1 through the nucleocapsid. J Virol 2008, 82:1389-1398. 10.1128/JVI.01912-07, 2224418, 18032513.
162. Zhou X, Pan S, Sun L, Corvera J, Lin SH, Kuang J. The HIV-1 p6/EIAV p9 docking site in Alix is autoinhibited as revealed by a conformation-sensitive anti-Alix monoclonal antibody. Biochem J 2008, 414:215-220. 10.1042/BJ20080642, 18476810.
163. Zhou X, Si J, Corvera J, Gallick GE, Kuang J. Decoding the intrinsic mechanism that prohibits ALIX interaction with ESCRT and viral proteins. Biochem J 2010, 432:525-534. 10.1042/BJ20100862, 20929444.
164. Dunn R, Klos DA, Adler AS, Hicke L. The C2 domain of the Rsp5 ubiquitin ligase binds membrane phosphoinositides and directs ubiquitination of endosomal cargo. J Cell Biol 2004, 165:135-144. 10.1083/jcb.200309026, 2172079, 15078904.
165. Usami Y, Popov S, Popova E, Gottlinger HG. Efficient and specific rescue of human immunodeficiency virus type 1 budding defects by a Nedd4-like ubiquitin ligase. J Virol 2008, 82:4898-4907. 10.1128/JVI.02675-07, 2346742, 18321969.
166. Itani OA, Campbell JR, Herrero J, Snyder PM, Thomas CP. Alternate promoters and variable splicing lead to hNedd4-2 isoforms with a C2 domain and varying number of WW domains. Am J Physiol Renal Physiol 2003, 285:F916-929.
167. Weiss ER, Popova E, Yamanaka H, Kim HC, Huibregtse JM, Gottlinger H. Rescue of HIV-1 release by targeting widely divergent NEDD4-type ubiquitin ligases and isolated catalytic HECT domains to Gag. PLoS Pathog 2010, 6:e1001107. 10.1371/journal.ppat.1001107, 2940739, 20862313.
168. Cimarelli A, Sandin S, Hoglund S, Luban J. Basic residues in human immunodeficiency virus type 1 nucleocapsid promote virion assembly via interaction with RNA. J Virol 2000, 74:3046-3057. 10.1128/JVI.74.7.3046-3057.2000, 111803, 10708419.
169. Muriaux D, Mirro J, Nagashima K, Harvin D, Rein A. Murine leukemia virus nucleocapsid mutant particles lacking viral RNA encapsidate ribosomes. J Virol 2002, 76:11405-11413. 10.1128/JVI.76.22.11405-11413.2002, 136761, 12388701.
170. Zhang Y, Qian H, Love Z, Barklis E. Analysis of the assembly function of the human immunodeficiency virus type 1 gag protein nucleocapsid domain. J Virol 1998, 72:1782-1789. 109467, 9499028.
171. Alfadhli A, Dhenub TC, Still A, Barklis E. Analysis of human immunodeficiency virus type 1 Gag dimerization-induced assembly. J Virol 2005, 79:14498-14506. 10.1128/JVI.79.23.14498-14506.2005, 1287545, 16282449.
172. Zhang H, Curreli F, Zhang X, Bhattacharya S, Waheed AA, Cooper A, Cowburn D, Freed EO, Debnath AK. Antiviral activity of alpha-helical stapled peptides designed from the HIV-1 capsid dimerization domain. Retrovirology 2011, 8:28. 10.1186/1742-4690-8-28, 3097154, 21539734.
173. Llewellyn GN, Hogue IB, Grover JR, Ono A. Nucleocapsid promotes localization of HIV-1 gag to uropods that participate in virological synapses between T cells. PLoS Pathog 2010, 6:e1001167. 10.1371/journal.ppat.1001167, 2965768, 21060818.
174. Ganser-Pornillos BK, Cheng A, Yeager M. Structure of full-length HIV-1 CA: a model for the mature capsid lattice. Cell 2007, 131:70-79. 10.1016/j.cell.2007.08.018, 17923088.
175. Li S, Hill CP, Sundquist WI, Finch JT. Image reconstructions of helical assemblies of the HIV-1 CA protein. Nature 2000, 407:409-413. 10.1038/35030177, 11014200.
176. Pornillos O, Ganser-Pornillos BK, Kelly BN, Hua Y, Whitby FG, Stout CD, Sundquist WI, Hill CP, Yeager M. X-ray structures of the hexameric building block of the HIV capsid. Cell 2009, 137:1282-1292. 10.1016/j.cell.2009.04.063, 2840706, 19523676.
177. Popov S, Strack B, Sanchez-Merino V, Popova E, Rosin H, Gottlinger HG. Human immunodeficiency virus type 1 and related primate lentiviruses engage clathrin through Gag-Pol or Gag. J Virol 2011, 85:3792-3801. 10.1128/JVI.02329-10, 3126147, 21289110.
178. Zhang F, Zang T, Wilson SJ, Johnson MC, Bieniasz PD. Clathrin facilitates the morphogenesis of retrovirus particles. PLoS Pathog 2011, 7:e1002119. 10.1371/journal.ppat.1002119, 3128127, 21738476.
179. Liang C, Rong L, Cherry E, Kleiman L, Laughrea M, Wainberg MA. Deletion mutagenesis within the dimerization initiation site of human immunodeficiency virus type 1 results in delayed processing of the p2 peptide from precursor proteins. J Virol 1999, 73:6147-6151. 112683, 10364374.
180. L'Hernault A, Weiss EU, Greatorex JS, Lever AM. HIV-2 genome dimerization is required for the correct processing of Gag: a second-site reversion in matrix can restore both processes in dimerization-impaired mutant viruses. J Virol 2012, 86:5867-5876. 10.1128/JVI.00124-12, 3347307, 22419802.
181. Shehu-Xhilaga M, Kraeusslich HG, Pettit S, Swanstrom R, Lee JY, Marshall JA, Crowe SM, Mak J. Proteolytic processing of the p2/nucleocapsid cleavage site is critical for human immunodeficiency virus type 1 RNA dimer maturation. J Virol 2001, 75:9156-9164. 10.1128/JVI.75.19.9156-9164.2001, 114484, 11533179.
182. Liang C, Rong L, Laughrea M, Kleiman L, Wainberg MA. Compensatory point mutations in the human immunodeficiency virus type 1 Gag region that are distal from deletion mutations in the dimerization initiation site can restore viral replication. J Virol 1998, 72:6629-6636. 109850, 9658109.